|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 2, 503-515, February 2003


Department of Cell Biology and Oncology, Istituto di Ricerche
Farmacologiche "Mario Negri," Consorzio Mario Negri Sud, 66030 Santa Maria Imbaro, Chieti, Italy
Glycerophosphoinositol 4-phosphate (GroPIns-4P) is a
biologically active, water-soluble phospholipase A metabolite derived from phosphatidylinositol 4-phosphate, whose cellular
concentrations have been reported to increase in Ras-transformed
cells. It is therefore important to understand its biological
activities. Herein, we have examined whether GroPIns-4P can regulate
the organization of the actin cytoskeleton, because this could be a
Ras-related function involved in cell motility and metastatic invasion.
We find that in serum-starved Swiss 3T3 cells, exogenously added GroPIns-4P rapidly and potently induces the formation of membrane ruffles, and, later, the formation of stress fibers. These actin structures can be regulated by the small GTPases Cdc42, Rac, and Rho.
To analyze the mechanism of action of GroPIns-4P, we selectively inactivated each of these GTPases. GroPIns-4P requires active Rac and
Rho, but not Cdc42, for ruffle and stress fiber formation, respectively. Moreover, GroPIns-4P induces a rapid translocation of the
green fluorescent protein-tagged Rac into ruffles, and increases the
fraction of GTP-bound Rac, in intact cells. The activation of Rac by
GroPIns-4P was near maximal and long-lasting. Interestingly, this
feature seems to be critical in the induction of actin ruffles by
GroPIns-4P.
ABBOTT SpA, Campoverde (Latina);
Department of Oncology and Neuroscience, Universita'
"G. D'Annunzio," Via dei Vestini 1, 66100 Chieti, Italy;
§Cutech Srl, Padova, Italy.
Corresponding author. E-mail address:
corda{at}negrisud.it.
This article has been cited by other articles:
![]() |
S. Mariggio, J. Sebastia, B. M. Filippi, C. Iurisci, C. Volonte, S. Amadio, V. De Falco, M. Santoro, and D. Corda A novel pathway of cell growth regulation mediated by a PLA2{alpha}-derived phosphoinositide metabolite FASEB J, December 1, 2006; 20(14): 2567 - 2569. [Abstract] [Full Text] [PDF] |
||||